From: Advances in targeted therapy for acute myeloid leukemia
ClinicalTrials. gov Identifier | Phase | Enrollment Number | Disease Conditons | Status | Lead Institution/Location |
---|---|---|---|---|---|
NCT02298166 | 3 | 276 | AML | Active, not recruiting | Ulm University Hospital, Germany |
NCT02400255 | 2 | 48 | AML | Active, recruiting | MD Anderson Cancer Center, USA |
NCT02400281 | 1,2 | 88 | AML | Active, not recruiting | MD Anderson Cancer Center, USA |
NCT02283177 | 2 | 48 | AML with FLT3 Mutations | Active, not recruiting | City of Hope, USA |
NCT03250338 | 2 | 322 | R/R AML with FLT3 mutations | Active, recruiting | City of Hope, USA |
NCT03258931 | 3 | 510 | FLT3 mutated AML | Active, recruiting | City of Hope, USA |